Altered CSF levels of monoamines in hereditary spastic paraparesis 10: A case series
- PMID: 31403080
- PMCID: PMC6659133
- DOI: 10.1212/NXG.0000000000000344
Altered CSF levels of monoamines in hereditary spastic paraparesis 10: A case series
Abstract
Objective: To perform a comprehensive clinical characterization and biochemical CSF profile analyses in 2 Swedish families with hereditary spastic paraparesis (HSP) 10 (SPG10) caused by 2 different mutations in the neuronal kinesin heavy chain gene (KIF5A).
Methods: Structured clinical assessment, genetic studies, and neuroradiologic and electrophysiological evaluations were performed in 4 patients from 2 families with SPG10. Additional CSF analysis was conducted in 3 patients with regard to levels of neurodegenerative markers and monoamine metabolism.
Results: All patients exhibited a complex form of HSP with a mild to moderate concurrent axonal polyneuropathy. The heterozygous missense mutations c.767A>G and c.967C>T in KIF5A were found. Wide intrafamilial phenotype variability was evident in both families. CSF analysis demonstrated a mild elevation of neurofilament light (NFL) chain in the patient with longest disease duration. Unexpectedly, all patients exhibited increased levels of the dopamine metabolite, homovanillic acid, whereas decreased levels of the noradrenergic metabolite, 3-methoxy-4-hydroxyphenylglycol, were found in 2 of 3 patients.
Conclusions: We report on CSF abnormalities in SPG10, demonstrating that NFL elevation is not a mandatory finding but may appear after long-standing disease. Impaired transportation of synaptic proteins may be a possible explanation for the increased dopaminergic turnover and noradrenergic deficiency identified. The reasons for these selective abnormalities, unrelated to obvious clinical features, remain to be explained. Our findings need further confirmation in larger cohorts of patients harboring KIF5A mutations.
Figures

Similar articles
-
Intrafamilial Phenotypic Variation in Taiwanese Patients with Hereditary Spastic Paraplegia and Charcot-Marie-Tooth Disease Due to KIF5A Mutations: A Cross-Sectional Observational Study.Acta Neurol Taiwan. 2025 Jun 11. doi: 10.4103/ant.ANT-D-25-00042. Online ahead of print. Acta Neurol Taiwan. 2025. PMID: 40518753
-
SPG10 is a rare cause of spastic paraplegia in European families.J Neurol Neurosurg Psychiatry. 2008 May;79(5):584-7. doi: 10.1136/jnnp.2007.137596. Epub 2008 Feb 1. J Neurol Neurosurg Psychiatry. 2008. PMID: 18245137
-
Mutations in the motor and stalk domains of KIF5A in spastic paraplegia type 10 and in axonal Charcot-Marie-Tooth type 2.Clin Genet. 2012 Aug;82(2):157-64. doi: 10.1111/j.1399-0004.2011.01717.x. Epub 2011 Jun 21. Clin Genet. 2012. PMID: 21623771
-
Role of kinesin-1 in the pathogenesis of SPG10, a rare form of hereditary spastic paraplegia.Neuroscientist. 2013 Aug;19(4):336-44. doi: 10.1177/1073858412451655. Epub 2012 Jul 10. Neuroscientist. 2013. PMID: 22785106 Review.
-
Evidence of kinesin heavy chain (KIF5A) involvement in pure hereditary spastic paraplegia.Neurology. 2004 Sep 28;63(6):1108-10. doi: 10.1212/01.wnl.0000138731.60693.d2. Neurology. 2004. PMID: 15452312 Review.
Cited by
-
Neurofilament light chain is a cerebrospinal fluid biomarker in hereditary spastic paraplegia.Ann Clin Transl Neurol. 2021 May;8(5):1122-1131. doi: 10.1002/acn3.51358. Epub 2021 Apr 5. Ann Clin Transl Neurol. 2021. PMID: 33819388 Free PMC article.
References
-
- Hirokawa N, Noda Y, Tanaka Y, Niwa S. Kinesin superfamily motor proteins and intracellular transport. Nat Rev Mol Cell Biol 2009;10:682–696. - PubMed
-
- Rinaldi F, Bassi MT, Todeschini A, et al. . A novel mutation in motor domain of KIF5A associated with an HSP/axonal neuropathy phenotype. J Clin Neuromuscul Dis 2015;16:153–158. - PubMed
LinkOut - more resources
Full Text Sources